<!DOCTYPE html>

<html lang="en">
<head>
<meta charset="utf-8"/>
<title>article209</title>
<style>
        body {
            font-family: Arial, sans-serif;
            margin: 0;
            padding: 0;
            background-color: #f3f3f3;
        }
        .container {
            max-width: 800px;
            margin: auto;
            background: #fff;
            padding: 20px;
            box-shadow: 0 0 10px rgba(0, 0, 0, 0.1);
        }
        h1, h2 {
            color: #333;
        }
        p {
            line-height: 1.6;
        }
        a {
            text-decoration: none;
            color: #5a5a5a;
        }
        a:hover {
            color: #000;
        }
    </style>
</head>
<body>
<div class="container"><p><a href="../index.html">Back to Index</a></p><li><a href="https://www.wikijournalclub.org/wiki/Early_TIPS" style="display:block; margin-bottom:10px;">Early TIPS Original</a></li>
<h2><strong>Early TIPS</strong></h2>
<div class="container">
<h2><strong></strong></h2>
<div class="container">
<div class="container">
<h2><strong></strong></h2>
<h2><strong></strong></h2>

    "Early Use of TIPS in Patients with Cirrhosis and Variceal Bleeding".<br/>
<br/>
The New England Journal of Medicine. 2010. 362:2370-2379.<br/>
PubMed • Full text • PDF<br/>
<br/>
<h2><strong>Contents</strong></h2><br/>
1 Clinical Question<br/>
2 Bottom Line<br/>
3 Major Points<br/>
4 Guidelines<br/>
5 Design<br/>
6 Population<br/>
6.1 Inclusion Criteria<br/>
6.2 Exclusion Criteria<br/>
6.3 Baseline Characteristics<br/>
7 Interventions<br/>
8 Outcomes<br/>
8.1 Primary Outcome<br/>
8.2 Secondary Outcomes<br/>
9 Funding<br/>
10 Further Reading<br/>
<br/>
<h2><strong>Clinical Question</strong></h2><br/>
In patients with Child-Pugh class C cirrhosis or class B with persistent endoscopic bleeding, does early use of TIPS with e-PTFE–covered stents improve outcomes compared to standard therapy with vasoactive drugs plus endoscopic therapy?<br/>
<br/>
<h2><strong>Bottom Line</strong></h2><br/>
In patients with cirrhosis and acute variceal bleeding at high risk for treatment failure, early use of TIPS with e-PTFE–covered stents significantly reduces treatment failure and mortality with no increase in risk of hepatic encephalopathy.<br/>
<br/>
<h2><strong>Major Points</strong></h2><br/>
The study investigated whether early initiation of TIPS improves outcomes in patients with cirrhosis and variceal bleeding who are at high risk for failure of standard treatment, which consists of vasoactive drugs and endoscopic band ligation. The results showed a significant reduction in rebleeding and mortality rates among patients receiving TIPS.<br/>
<br/>
<h2><strong>Guidelines</strong></h2><br/>
As of August 2017, guidelines have not been published that reflect the results of this trial.<br/>
<br/>
<h2><strong>Design</strong></h2><br/>
Multicenter, randomized, controlled trial<br/>
N=63 patients with cirrhosis and acute variceal bleeding<br/>
Pharmacotherapy-EBL group (n=31)<br/>
Early-TIPS group (n=32)<br/>
Setting: 9 European centers<br/>
Enrollment: May 2004 to March 2007<br/>
Primary follow-up: median 16 months<br/>
Analysis: Intention-to-treat<br/>
<br/>
<h2><strong>Population</strong></h2><br/>
Inclusion Criteria<br/>
Cirrhosis with acute esophageal variceal bleeding treated with vasoactive drugs, endoscopic treatment, and prophylactic antibiotics<br/>
Child–Pugh class C disease or class B with active bleeding at diagnostic endoscopy<br/>
Exclusion Criteria<br/>
Age &gt;75, pregnancy, hepatocellular carcinoma outside Milano criteria, creatinine &gt;3 mg/dL, Child–Pugh score &gt;13, previous portosystemic shunt, bleeding from isolated gastric or ectopic varices, total portal-vein thrombosis, heart failure<br/>
Baseline Characteristics<br/>
No significant between-group differences at baseline<br/>
<br/>
<h2><strong>Interventions</strong></h2><br/>
Pharmacotherapy-EBL group: continuation of vasoactive-drug therapy followed by propranolol or nadolol and long-term EBL, using TIPS as rescue therapy if needed<br/>
Early-TIPS group: early use of TIPS within 72 hours with e-PTFE–covered stents<br/>
<br/>
<h2><strong>Outcomes</strong></h2><br/>
Primary Outcome<br/>
Failure to control bleeding or prevention of clinically significant variceal rebleeding within 1 year<br/>
Secondary Outcomes<br/>
Mortality at 6 weeks and 1 year<br/>
Development of liver-related complications<br/>
Number of days in intensive care and percentage of follow-up days spent in hospital<br/>
<h2><strong>Funding</strong></h2><br/>
Partially funded by grants from multiple institutions including Instituto de Salud Carlos III (Spain), Ministerio de Educación y Ciencia (Spain), University Hospital Center of Toulouse, Fund for Scientific Research — Flanders, and an educational grant from Gore.<br/>
<br/>
<h2><strong>Further Reading</strong></h2><br/>
Further details are available in the full text of the article at NEJM.org.
    <p></p>
</div>
</div>
</div>
</div>
</body>
</html>
